Medical Advocates
HIV Infection/Disease
  Non-Occupational
Post-Exposure Prophylaxis
General Reports
 Guidelines and Recommendations
 Diagnostics/Monitoring
 Drugs
 Counseling
 High-Risk Populations
 National Studies



 
HIV PEP Main Page HIV Main Page New/Newsworthy Home Page    
Last Update:  October 11, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the .Adobe Acrobat Reader
General  Studies/Issues
       
     Journal Papers, Abstracts, and Commentaries
 
 
A WEEK-IN-REVIEW FEATURED REPORT
Is screening for sexually transmitted infections in men who have sex with men who receive
non-occupational HIV post-exposure prophylaxis worthwhile?
Hamlyn E, McAllister J, Winston A, et al 
Sex Transm Infect. 2006 Feb;82(1):21-23.
 Abstract
 
Seroconversion Following Nonoccupational Postexposure Prophylaxis against HIV.
Roland ME, Neilands TB, Krone MR, et al  
Clin Infect Dis. 2005 Nov 15;41(10):1507-13.
Abstract

HIV Postexposure Prophylaxis in Sexual Assault: Current Practice and Patient
Adherence to Treatment Recommendations in a Large Urban Teaching Hospital.
Linden JA, Oldeg P, Mehta SD, et al 
Acad Emerg Med. 2005 Jul;12(7):640-646.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
 
Effectiveness of HIV post-exposure prophylaxis following sexual exposure (PEPSE):
a systematic review
Doyle J.
 (4th IAS Conference)
 Abstract

Feasibility of providing post exposure prophylaxis (PEP) to rape survivors in refugee settings
chilperoord M., Lukugu G., Doedens W., Spiegel P.
 (XVI International AIDS Conference)
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
 HIV Post-Exposure Prophylaxis Following Sexual Exposure is Started Too Late for Optimal Benefit
A Kindrick, H Tang, C Sterkenberg, 
(13 CROI)
 PDF Poster     Abstract

POSTER
Seroconversion following Non-Occupational Post-exposure Prophylaxis
M Roland, T Coates, J Tapia, et al.    
 (11 CROI)
 PDF Poster           Abstract
 
 

Acceptability, Behavioral Impact, and Possible Efficacy of Post-Sexual-Exposure
Chemoprophylaxis (PEP) for HIV  
M. Schechter, R. F. Lago , R. Ismerio , et al. 
 (9RETRO)
 Abstract
Guidelines and Recommendations
       

     Journal Papers, Abstracts, and Commentaries

  FULL-TEXT REPORT
 Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other
Nonoccupational Exposure to HIV in the United States: Recommendations from the
U.S. Department of Health and Human Services
CDC 
MMWR Jan 21, 2005 / Vol. 54 / No. RR--2
 Paper
 		  
     Conference Reports, Abstracts, and Posters
 
  Guidelines for Post-exposure Prophylaxis for HIV in Developing Countries
M Vitoria E Beck, S Mandalia, et al  
(13 CROI)
 Abstract
Diagnostics/Monitoring
       

      Journal Papers, Abstracts, and Commentaries

  HIV RNA Testing in the Context of Nonoccupational Postexposure Prophylaxis.
Roland ME, Elbeik TA, Kahn JO, et al 
J Infect Dis. 2004 Aug 1;190(3):598-604.
 Abstract
Drugs
       

ART: Multiple Drugs

     Journal Papers, Abstracts, and Commentaries

 
A WEEK-IN-REVIEW FEATURED REPORT
 Assessment of adverse events associated with antiretroviral regimens for postexposure
prophylaxis for occupational and nonoccupational exposures to prevent transmission of
human immunodeficiency virus.
Luque A, Hulse S, Wang D, et al 
 Infect Control Hosp Epidemiol. 2007 Jun;28(6):695-701.
 Abstract

'The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure
prophylaxis.
 Winston A, McAllister J, Amin J, et al
HIV Med. 2005 May;6(3):191-197
 Abstract

Tenofovir

     Journal Papers, Abstracts, and Commentaries
 
  Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure
Prophylaxis (NPEP) in a Boston Community Health Center.
Mayer KH, Mimiaga MJ, Cohen D,et al 
J Acquir Immune Defic Syndr. 2007 Dec 20
 Abstract

    Conference Reports, Abstracts, and Posters

 
Tenofovir-based regimens for Non-Occupational Post-Exposure Prophylaxis (NPEP): improved
tolerability and adherence compared to AZT-based regimens
Mayer K., Mimiaga M., Cohen D., et al 
(XVI  International AIDS Conference )
 Abstract

Tenofovir/3TC for Non-Occupational Post-exposure prophylaxis (NPEP):
Improved tolerability and adherence compared to AZT/3TC
Mayer K., Goldhammer H., Cohen D., et al,
(3rd IAS)
 Abstract
Counseling
       

     Conference Reports, Abstracts, and Posters

  A Randomized Trial of Standard versus Enhanced Risk Reduction Counseling for Individuals
Receiving Post-exposure Prophylaxis following Sexual Exposures to HIV
M Roland, T Neilands, M Krone, et al 
(13 CROI)
 Abstract

HIV PEP Main Page HIV Main Page Main New/Newsworthy Home Page    

 Non-Occupational Post-Exposure Prophylaxis